Full Length Research Paper
References
Andrews GS (1949). Latent carcinoma of the prostate. J. Clin. Path. 2(3):197-208. Crossref |
||||
Brawn PN, Kuhl D, Speights VO, Johnson CF, Lind M (1995). The incidence of unsuspected metastases from clinically benign prostate glands with latent prostate carcinoma. Arch. Pathol. Lab. Med. 119(8):731-733. Pubmed |
||||
Breslow N, Chan CW, Dhom G, Drury RA, Franks LM, Gellei B, Lee YS, Lundberg S, Sparke B, Sternby NH, Tulinius H (1977). Latent carcinoma of prostate at autopsy in seven areas. Int. J. Cancer. 20(5):680-688. Crossref |
||||
Drake MT (2013). Osteoporosis and cancer. Curr. Osteoporos. Rep. 11(3):163-170. Crossref |
||||
Gleason DF (1992). Histologic grading of prostate cancer: a perspective. Hum. Pathol. 23:273-279. Crossref |
||||
Hsing AW, Tsao L, Devesa SS (2000). International trends and patterns of prostate cancer incidence and mortality. Int. J. Cancer. 85(1):60-67. Crossref |
||||
Kido M, Hitosugi M, Ishii K, Kamimura S, Joh K (2015). Latent prostate cancer in Japanese men who die unnatural deaths: A forensic autopsy study. Prostate. 75(9):917-922. Crossref |
||||
Leal J, Hamdy F, Wolstenholme J (2014). Estimating age and ethnic variation in the histological prevalence of prostate cancer to inform the impact of screening policies. Int. J. Urol. 21(8):786-792. Crossref |
||||
Levine B, Titus JM, Moore K, Fowler D (2004). Use of prostate specific antigen in the identification of semen in postmortem cases. Am. J. Forensic Med. Pathol. 25(4):288-290. Crossref |
||||
Sakr WA, Grignon DJ, Haas GP, Schomer KL, Heilbrun LK, Cassin BJ, Powell J, Montie JA, Pontes JE, Crissman JD (1995). Epidemiology of high grade prostatic intraepithelial neoplasia. Pathol. Res. Pract. 191(9):838-841. Crossref |
||||
Siegel R, Ma J, Zou Z, Jemal A (2014). Cancer statistics, 2014. CA. Cancer J. Clin. 64:9-29. Crossref |
||||
Takahashi S, Shirai T, Hasegawa R, Imaida K, Ito N (1992). Latent prostatic carcinomas found at autopsy in men over 90 years old. Jpn. J. Clin. Oncol. 22(2):117-121. Pubmed |
||||
Tian W, Osawa M, Horiuchi H, Tomita Y (2004). Expression of the prolactin-inducible protein (PIP/GCDFP15) gene in benign epithelium and adenocarcinoma of the prostate. Cancer Sci. 95(6):491-495. Crossref |
||||
Yatani R, Chigusa I, Akazaki K, Stemmermann GN, Welsh RA, Correa P (1982). Geographic pathology of latent prostatic carcinoma. Int. J. Cancer. 29(6):611-616. Crossref |
||||
Zare-Mirzaie A, Balvayeh P, Imamhadi MA, Lotfi M (2012). The frequency of latent prostate carcinoma in autopsies of over 50 years old males, the Iranian experience. Med. J. Islam Repub. Iran. 26(2):73-77. Pubmed |
||||
Zhu YP, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, Shen YJ, Shi GH (2009). Prevalence of incidental prostate cancer in patients undergoing radical cystoprostatectomy: Data from China and other Asian countries. Asian J. Androl. 11(1):104-108. Crossref |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0